期刊
ANTIVIRAL RESEARCH
卷 130, 期 -, 页码 46-49出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.antiviral.2016.03.013
关键词
Flavivirus; NITD008; Antiviral; Nucleoside analog; Tick-borne
资金
- CDC core funding
There are currently no antiviral therapies available for the tick-borne flaviviruses associated with hemorrhagic fevers: Kyasanur Forest disease virus (KFDV), both classical and the Alkhurma hemorrhagic fever virus (AHFV) subtype, and Omsk hemorrhagic fever virus (OHFV). In this brief study, we describe the in vitro antiviral activity of adenosine analog NITD008 against KFDV, AHFV, OHFV, as well as Tick borne Encephalitis virus (TBEV). Alongside the well-established activity of NITD008 against mosquito borne flaviviruses, our results have demonstrated the feasibility of identifying nucleoside analog inhibitors that have pan-flavivirus activity. Published by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据